English
Insider transactions
EDGARenVVeno Medical Corporation
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-19.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 4 transactions, 5,191 shares
- Sum of shares × price per share: 4,921.586
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–11 of 11
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-11 Filed 2026-09-14 | Duhay Francis Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 11 | 11.2100 | 123.31Derived: shares × price per share. Exact value 123.3100. | 2,351 | Direct (D) | Yes | F1
| Open filing 0001493152-26-042629 Read from the filing’s XML Dispute this row |
| 2026-06-11 Filed 2026-06-12 | Duhay Francis Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 140 | 10.305 | 1,442.7Derived: shares × price per share. Exact value 1442.700. | 2,362 | Direct (D) | Yes | F1
| Open filing 0001493152-26-028426 Read from the filing’s XML Dispute this row |
| 2026-03-12 Filed 2026-03-13 | Duhay Francis Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 140 | 11.5224 | 1,613.136Derived: shares × price per share. Exact value 1613.1360. | 2,502 | Direct (D) | Yes | F1, F2
| Open filing 0001493152-26-010047 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | Alavi Hamed Officer: Chief Technology Officer | JOther acquisition or disposition (describe transaction) | Disposed (D) | 50,000 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001493152-25-028394 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | BERMAN ROBERT ANDREW Director · Officer: Chief Executive Officer | JOther acquisition or disposition (describe transaction) | Disposed (D) | 200,000 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001493152-25-028396 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | Glickman Marc H. Officer: SVP Chief Medical Officer | JOther acquisition or disposition (describe transaction) | Disposed (D) | 100,000 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001493152-25-028392 Read from the filing’s XML Dispute this row |
| 2025-12-11 Filed 2025-12-15 | Gray Robert Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 135,883 | 0 | — | 135,883 | Direct (D) | No | F1
| Open filing 0001493152-25-027834 Read from the filing’s XML Dispute this row |
| 2025-12-11 Filed 2025-12-15 | Duhay Francis Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 135,883 | 0 | — | 135,883 | Direct (D) | No | F1
| Open filing 0001493152-25-027848 Read from the filing’s XML Dispute this row |
| 2025-12-11 Filed 2025-12-15 | Jenusaitis Matthew Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 135,883 | 0 | — | 135,883 | Direct (D) | No | F1
| Open filing 0001493152-25-027832 Read from the filing’s XML Dispute this row |
| 2025-12-11 Filed 2025-12-15 | Shrivastava Sanjay Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 135,883 | 0 | — | 135,883 | Direct (D) | No | F1
| Open filing 0001493152-25-027826 Read from the filing’s XML Dispute this row |
| 2025-12-11 Filed 2025-12-12 | Duhay Francis Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,900 | 0.3556 | 1,742.44Derived: shares × price per share. Exact value 1742.4400. | 92,544 | Direct (D) | Yes | F1, F2
| Open filing 0001493152-25-027510 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.
Showing 1–17 of 17
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. Partly reported under another manager | 36,166 SH | 282,095 dollars | Unchanged Prior quarter: 36,166 | Open filing 0001000097-26-000012 Filed 2026-11-16 Dispute this row |
| CM Management, LLC | 17,142 SH | 133,708 dollars | Lower by 18,572 Prior quarter: 35,714 | Open filing 0001841857-26-000004 Filed 2026-11-12 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 15,314 SH | 129,556 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,287 SH | 53,188 dollars | Unchanged Prior quarter: 6,287 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 5,219 SH | 44,048 dollars | Higher by 11 Prior quarter: 5,208 | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 2,184 SH | 18,477 dollars | Unchanged Prior quarter: 2,184 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| UBS Group AG Partly reported under another manager | 1,965 SH | 15,327 dollars | Higher by 1,964 Prior quarter: 1 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| Westside Investment Management, Inc. | 1,525 SH | 11,895 dollars | Unchanged Prior quarter: 1,525 | Open filing 0001538383-26-000005 Filed 2026-11-02 Dispute this row |
| Tower Research Capital LLC (TRC) Partly reported under another manager | 580 SH | 4,524 dollars | Higher by 249 Prior quarter: 331 | Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row |
| Mirae Asset Global Investments Co., Ltd. | 539 SH | 4,204 dollars | Unchanged Prior quarter: 539 | Open filing 0000905148-26-004586 Filed 2026-10-29 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 414 SH | 3,229 dollars | Unchanged Prior quarter: 414 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| Vanguard Global Advisers, LLC | 77 SH | 651 dollars | Unchanged Prior quarter: 77 | Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 59 SH | 460 dollars | Unchanged Prior quarter: 59 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| WELLS FARGO COMPANY/MN Partly reported under another manager | 57 SH | 445 dollars | Lower by 57 Prior quarter: 114 | Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row |
| OSAIC HOLDINGS, INC. Partly reported under another manager | 7 SH | 60 dollars | Unchanged Prior quarter: 7 | Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row |
| GROUP ONE TRADING LLC | 2 SH | 17 dollars | Unchanged Prior quarter: 2 | Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row |
| Caitong International Asset Management Co., Ltd | 1 SH | 8 dollars | Not in the prior quarter’s filings read | Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Allied Private Wealth LLC 88 SH
- BARCLAYS PLC 2 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Thomas A. Satterfield, Jr. Common Stock, $0.00001 par value per share | 4.8 | 33,470.00 | 09/30/2026 Filed 2026-11-10 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-125054 Dispute this row |
| Braeden Lichti Common Stock, par value $0.00001 per share | 0.00 | 0.00 | 09/11/2026 Filed 2026-09-15 | SCHEDULE 13D/AAmendment 1 | Open filing 0001213900-26-100114 Dispute this row |
| Northstrive Fund II LP Common Stock, par value $0.00001 per share | 0.00 | 0.00 | 09/11/2026 Filed 2026-09-15 | SCHEDULE 13D/AAmendment 1 | Open filing 0001213900-26-100114 Dispute this row |
| Perceptive Advisors LLC Common Stock, $0.00001 par value | 3.5 | 24,605 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 8 | Open filing 0001193125-26-352645 Dispute this row |
| Joseph Edelman Common Stock, $0.00001 par value | 3.5 | 24,605 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 8 | Open filing 0001193125-26-352645 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.00001 par value | 3.5 | 24,605 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 8 | Open filing 0001193125-26-352645 Dispute this row |
| Perceptive Advisors LLC Common Stock, $0.00001 par value | 9.99 | 68,525 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 7 | Open filing 0001193125-26-226559 Dispute this row |
| Joseph Edelman Common Stock, $0.00001 par value | 9.99 | 68,525 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 7 | Open filing 0001193125-26-226559 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.00001 par value | 9.99 | 68,525 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 7 | Open filing 0001193125-26-226559 Dispute this row |
| Kingdon Capital Management, L.L.C. Common Stock, $0.00001 par value | 5.5 | 36,166.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003332 Dispute this row |
| M. Kingdon Offshore Master Fund, L.P. Common Stock, $0.00001 par value | 5.5 | 36,166.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003332 Dispute this row |
| Kingdon GP, LLC Common Stock, $0.00001 par value | 5.5 | 36,166.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003332 Dispute this row |
| Mark Kingdon Common Stock, $0.00001 par value | 5.5 | 36,166.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003332 Dispute this row |
| Braeden Lichti Common Stock, par value $0.00001 per share | 5.05 | 33,151.00 | 02/20/2026 Filed 2026-02-20 | SCHEDULE 13D | Open filing 0001213900-26-018626 Dispute this row |
| Northstrive Fund II LP Common Stock, par value $0.00001 per share | 3.07 | 20,129.00 | 02/20/2026 Filed 2026-02-20 | SCHEDULE 13D | Open filing 0001213900-26-018626 Dispute this row |
| Northstrive Fund II LP Common Stock, par value $0.00001 per share | 3.07 | 20,129.00 | 02/20/2026 Filed 2026-02-20 | SCHEDULE 13D | Open filing 0001213900-26-018625 Dispute this row |
| Braeden Lichti Common Stock, par value $0.00001 per share | 5.05 | 33,151.00 | 02/20/2026 Filed 2026-02-20 | SCHEDULE 13D | Open filing 0001213900-26-018625 Dispute this row |
| Braeden Lichti Common Stock, $0.00001 par value per share | 5.05 | 33,151.00 | 02/10/2026 Filed 2026-02-10 | SCHEDULE 13G | Open filing 0001213900-26-014296 Dispute this row |
| Northstrive Fund II LP Common Stock, $0.00001 par value per share | 3.07 | 20,129.00 | 02/10/2026 Filed 2026-02-10 | SCHEDULE 13G | Open filing 0001213900-26-014296 Dispute this row |
| Northstrive Fund II LP Common Stock, $0.00001 par value per share | 3.07 | 20,129.00 | 02/10/2026 Filed 2026-02-10 | SCHEDULE 13G | Open filing 0001213900-26-014300 Dispute this row |
| Braeden Lichti Common Stock, $0.00001 par value per share | 5.05 | 33,151.00 | 02/10/2026 Filed 2026-02-10 | SCHEDULE 13G | Open filing 0001213900-26-014300 Dispute this row |
| Perceptive Advisors LLC Common Stock, $0.00001 par value | 9.99 | 2,048,515 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 6 | Open filing 0001193125-26-054529 Dispute this row |
| Joseph Edelman Common Stock, $0.00001 par value | 9.99 | 2,048,515 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 6 | Open filing 0001193125-26-054529 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.00001 par value | 9.99 | 2,048,515 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 6 | Open filing 0001193125-26-054529 Dispute this row |
| Thomas A. Satterfield, Jr. Common Stock, $0.00001 par value per share | 9.0 | 1,822,500.00 | 11/14/2025 Filed 2025-11-19 | SCHEDULE 13G | Open filing 0001104659-25-114096 Dispute this row |
| Nantahala Capital Management, LLC Common Stock, $0.00001 par value | 3.46 | 688,940.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-25-112662 Dispute this row |
| Wilmot B. Harkey Common Stock, $0.00001 par value | 3.46 | 688,940.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-25-112662 Dispute this row |
| Daniel Mack Common Stock, $0.00001 par value | 3.46 | 688,940.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-25-112662 Dispute this row |
| Kingdon Capital Management, L.L.C. Common Stock, $0.00001 par value | 7.1 | 1,359,261.00 | 09/02/2025 Filed 2025-09-09 | SCHEDULE 13G | Open filing 0000919574-25-005609 Dispute this row |
| M. Kingdon Offshore Master Fund, L.P. Common Stock, $0.00001 par value | 6.6 | 1,265,845.00 | 09/02/2025 Filed 2025-09-09 | SCHEDULE 13G | Open filing 0000919574-25-005609 Dispute this row |
| Kingdon GP, LLC Common Stock, $0.00001 par value | 6.6 | 1,265,845.00 | 09/02/2025 Filed 2025-09-09 | SCHEDULE 13G | Open filing 0000919574-25-005609 Dispute this row |
| Mark Kingdon Common Stock, $0.00001 par value | 7.1 | 1,359,261.00 | 09/02/2025 Filed 2025-09-09 | SCHEDULE 13G | Open filing 0000919574-25-005609 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,544,215 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 17,857 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 170,508 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 262,403 |
Filings made before the SEC required XML are listed, not extracted.